MYCN and neuroblastoma: John T. Powers (Dell Medical School at the University of Texas at Austin) gave an overview of the mechanisms of let-7 disruption in neuroblastoma [43] and showed that multiple isoforms of let-7 agonist H19 long noncoding RNA (lncRNA) are highly expressed in MYCN non-amplified neuroblastoma.